Validation of the French 3-year prognostic score for death or lung transplant in the United States cystic fibrosis population

Author(s):  
Kathleen J. Ramos ◽  
Travis Hee Wai ◽  
Jenna Sykes ◽  
Xiayi Ma ◽  
Anne L. Stephenson ◽  
...  
CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A142-A143
Author(s):  
Kathleen Ramos ◽  
Miranda Bradford ◽  
Eric Morrell ◽  
Ranjani Somayaji ◽  
Siddhartha Kapnadak ◽  
...  

2021 ◽  
Vol 20 ◽  
pp. S20
Author(s):  
S. Seyoum ◽  
M. Regenstein ◽  
J. Erdo ◽  
K. Reno ◽  
O. Dieni.

2011 ◽  
Vol 141 (3) ◽  
pp. 828-832.e1 ◽  
Author(s):  
Farhan Zafar ◽  
Jeffrey S. Heinle ◽  
Marc G. Schecter ◽  
Joseph W. Rossano ◽  
George B. Mallory ◽  
...  

2018 ◽  
Vol 57 (2) ◽  
Author(s):  
Ravikiran Vasireddy ◽  
Sruthi Vasireddy ◽  
Barbara A. Brown-Elliott ◽  
Alexander L. Greninger ◽  
Rebecca M. Davidson ◽  
...  

ABSTRACTWe characterize three respiratory isolates of the recently described speciesMycobacterium talmoniaerecovered in Texas, Louisiana, and Massachusetts, including the first case of disease in a patient with underlying cystic fibrosis. The three isolates had a 100% match toM. talmoniaeNE-TNMC-100812Tby complete 16S rRNA,rpoBregion V, andhsp65 gene sequencing. Core genomic comparisons between one isolate and the type strain revealed an average nucleotide identity of 99.8%. The isolates were susceptible to clarithromycin, amikacin, and rifabutin, while resistance was observed for tetracyclines, ciprofloxacin, and linezolid.M. talmoniaeshould be added to the list of potential pulmonary pathogens, including in the setting of cystic fibrosis.


2011 ◽  
Vol 91 (11) ◽  
pp. 1293-1296 ◽  
Author(s):  
Tse-Ling Fong ◽  
Yong W. Cho ◽  
Linda Hou ◽  
Ian V. Hutchinson ◽  
Richard G. Barbers ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document